Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Net sales declined due to lower shipment volumes of gaming machine components and other products, the end of demand for the transition from 3G to LTE (4G), and delays in developing and launching new 5G and edge AI products. Ordinary profit increased due to ¥4,969 million in equity-method investment income from Cellebrite. Net income declined because the gain on changes in Cellebrite's equity interests decreased by ¥12,832 million from the previous year.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥9,907 million (YoY -8.6%) |
| Operating profit | ¥-15 million |
| Ordinary income | ¥5,133 million (YoY +623.1%) |
| Profit attributable to owners of the parent | ¥9,663 million (YoY -43.9%) |
| Net income per share | ¥441.53 |
| Operating Margin | Current fiscal year △0.2％ / Previous period Not disclosed |
| Equity ratio | End of the current fiscal period 89.7％ / End of previous period 89.5％ |
| Total assets | ¥53,652 million |
| Net assets | ¥48,181 million |
| Cash flows from operating activities | ¥1,521 million |
| Cash flows from investing activities | ¥6,676 million |
| Cash flows from financing activities | ¥-8,087 million |
| Cash and cash equivalents at end of period | ¥2,093 million |
| Full-year earnings forecast | Net Sales ¥19,222 million (YoY +94.0%) / Operating profit ¥2,131 million / Ordinary income ¥8,300 million (YoY +61.7%) / Net income ¥7,600 million (YoY -21.4%) |
| Annual Dividend Forecast | ¥100 → ¥50（-50.0%） |
| Payout ratio | 11.3％ |
| Segment revenue | Global Data Intelligence business ¥1,293 million (YoY +8.2%), Entertainment-related business ¥5,477 million (YoY -6.6%), IT-Related Business ¥3,158 million (YoY -16.9%), Wellness ― |
| Segment profit | Global Data Intelligence business ¥140 million (YoY -14.6%), Entertainment-related business ¥648 million (YoY -1.4%), IT-Related Business ¥332 million (YoY +29.8%), Wellness ¥-30 million |
| Depreciation and amortization | ¥242,613 thousand |
| Impairment loss | “—” for the current fiscal year; none recorded |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥2,238 thousand, Gain on changes in equity interests ¥4,727,593 thousand, Gain on reversal of subscription rights to shares ¥27 thousand, Gain on receipt of government subsidies ¥74,540 thousand / Extraordinary loss Loss on disposal of inventories ¥1,610 thousand, Other ¥81 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Added: — companies; removed: — companies |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 24,007,728 shares |
| Treasury Shares at Period-End | 2,489,816 treasury shares |
| Factors Behind Changes in Business Performance | Net sales declined due to lower shipment volumes of gaming machine components and other products, the end of demand for the transition from 3G to LTE (4G), and delays in developing and launching new 5G and edge AI products. Ordinary profit increased due to ¥4,969 million in equity-method investment income from Cellebrite. Net income declined because the gain on changes in Cellebrite's equity interests decreased by ¥12,832 million from the previous year. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The main factors behind the decline in net sales were lower shipment volumes of gaming machine components and other products in the entertainment-related business, the end of demand for the transition from 3G to LTE (4G) in the IT-related business, and lower shipment volumes due to delays in developing and launching new 5G and edge AI products. The increase in ordinary profit was attributable to the recognition of ¥4,969 million in equity-method investment income from Cellebrite. The decline in net income was attributable to a ¥12,832 million decrease from the previous year in the gain on changes in Cellebrite's equity interests.